4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-015898
Options or other derivatives
- Chief Legal Officer acquired 68,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ali-Jackson Kamil Chief Legal Officer | 2019-03-01 | Grant or award · Restricted stock units | +68,700 | 68,700 | D | ||
Loading xslF345X03/doc4.xml…